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Deldicque L, Atherton P, Patel R, Theisen D, Nielens H, Rennie
MJ, Francaux M. Effects of resistance exercise with and without
creatine supplementation on gene expression and cell signaling in human
skeletal muscle. J Appl Physiol 104: 371–378, 2008. First published
November 29, 2007; doi:10.1152/japplphysiol.00873.2007.—To test the
hypothesis that creatine supplementation would enhance the anabolic
responses of muscle cell signaling and gene expression to exercise, we
studied nine subjects who received either creatine or a placebo
(maltodextrin) for 5 days in a double-blind fashion before undergoing
muscle biopsies: at rest, immediately after exercise (10  10 repeti-
tions of one-leg extension at 80% 1 repetition maximum), and 24 and
72 h later (all in the morning after fasting overnight). Creatine
supplementation decreased the phosphorylation state of protein kinase
B (PKB) on Thr308 at rest by 60% (P  0.05) and that of eukaryotic
initiation factor 4E-binding protein on Thr37/46 (4E-BP1) by 30%
24 h postexercise (P  0.05). Creatine increased mRNA for collagen
1 (1), glucose transporter-4 (GLUT-4), and myosin heavy chain I at
rest by 250%, 45%, and 80%, respectively, and myosin heavy chain
IIA (MHCIIA) mRNA immediately after exercise by 70% (all P 
0.05). Immediately after exercise, and independent of creatine, mRNA
for muscle atrophy F-box (MAFbx), MHCIIA, peroxisome prolifera-
tor-activated receptor  coactivator-1, and interleukin-6 were up-
regulated (60–350%; P 0.05); the phosphorylation state of p38 both
in the sarcoplasm and nucleus were increased (12- and 25-fold,
respectively; both P 0.05). Concurrently, the phosphorylation states
of PKB (Thr308) and 4E-BP1 (Thr37/46) were decreased by 50% and
75%, respectively (P  0.05). Twenty-four hours postexercise,
MAFbx, myostatin, and GLUT-4 mRNA expression decreased below
preexercise values (35 to 50%; P  0.05); calpain 1 mRNA
increased 70% 72 h postexercise (P  0.05) and at no other time. In
conclusion, 5 days of creatine supplementation do not enhance ana-
bolic signaling but increase the expression of certain targeted genes.
mitogen-activated protein kinase; protein kinase B; protein synthesis
CREATINE SUPPLEMENTATION HAS BEEN used in various contexts,
not only among athletes as an ergogenic aid for improving
muscle power output during high-intensity exercise (16) but
also as a potential therapeutic agent for patients suffering from
general muscle wasting and myopathies (24, 37, 40). Creatine
supplementation leads to an increase in muscle fiber area when
associated with resistance exercise training (39) or in the case
of muscle regeneration after atrophy (18). More recently,
creatine supplementation has been shown to amplify the in-
crease in satellite cell number and myonuclei concentration in
human skeletal muscle fibers during 4–16 wk of resistance
training. These creatine-induced adaptations were associated
with an enhanced muscle fiber growth in response to strength
training (32).
Evidence accumulated over the past 15 years suggests that
the primary mechanism by which creatine exerts its anabolic
effect in healthy subjects who are weight training is by allow-
ing them to work at a higher proportion of their maximal
voluntary contraction force and thus increase the training
stimulus (16). However, this mechanism may not explain the
higher force production observed in patients suffering from
myopathy (24, 37). Therefore, the search for alternative mech-
anisms for the beneficial effects of creatine has been under
scrutiny. Several studies suggest that creatine could be more
effective in muscle submitted to degeneration/regeneration
process induced by exercise (32), immobilization (18), or
disease (24, 37). Therefore, we also hypothesized that creatine
would slow down the degeneration phase and accelerate the
regeneration phase after high-intensity exercise, which usually
occur 1 and 3 days postexercise, respectively (15).
In two previous studies, we were unable to detect any
difference in the myofibrillar or sarcoplasmic protein synthetic
rates or the breakdown rate of human muscle after creatine
supplementation whether at rest (26) or postexercise (25). This
lack of effect of creatine after exercise might have been
explained by the timing of the measurements made. For exam-
ple, we measured the protein turnover rates immediately after
exercise following 5 days of supplementation, and it might
have been that the creatine-plus-exercise effects were present
at a later time point. Indeed, exercise-induced increases in
protein synthesis can last for up to 72 h (29). Furthermore,
there may be intricate changes in translational signaling attrib-
utable to creatine that are undetectable by direct measures of
muscle protein synthesis. Indeed, many recent studies in hu-
man muscle have implicated changes in such candidate path-
ways with resistance exercise, including the PKB (protein
kinase B)-mTOR and the MAPK (mitogen-activated protein
kinase) pathways, key cascades in the regulation of skeletal
muscle protein synthesis, and remodelling by resistance exer-
cise (10, 13, 14, 20, 42).
Furthermore, in the past studies, we did not examine the
possibility of a “priming” of muscle gene expression that could
be important for forthcoming synthetic responses to resistance
exercise or indeed other adaptive processes. In support of the
notion for the modulation of gene expression by creatine, there
has been evidence of increased myosin heavy chain (MHC)
and IGF-I and II in human subjects after creatine ingestion (11,
Address for reprint requests and other correspondence: M. Francaux, Place
Pierre de Coubertin 1, B-1348 Louvain-la-Neuve, Belgium (e-mail: marc.
francaux@uclouvain.be).
The costs of publication of this article were defrayed in part by the payment
of page charges. The article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
J Appl Physiol 104: 371–378, 2008.
First published November 29, 2007; doi:10.1152/japplphysiol.00873.2007.
8750-7587/08 $8.00 Copyright © 2008 the American Physiological Societyhttp://www. jap.org 371
 o
n
 O
ctober 10, 2008 
jap.physiology.org
D
ow
nloaded from
 
43). Furthermore, such gene expression changes, either in the
satellite cells or in the myofiber after each exercise session,
could be one mechanism by which the induction of satellite
cell nuclei into the myofiber occurs after several weeks of
resistance training, when coupled with creatine supplemen-
tation (32).
The aims of the present study were to test whether 5 days of
creatine supplementation induce short-term changes in gene
expression and cellular signaling at rest and after a single bout
of exercise. We hypothesized that short-term creatine supple-
mentation would increase expression of genes associated with
the control of muscle mass, phenotype, and metabolism and
augment anabolic signal transduction activity through the
MAPK and the PKB pathways.
METHODS
Subjects. Nine healthy young men (21.7  0.55 y, BMI 24  0.9
kg/m2) who did not partake in any formal resistance exercise regime,
were recruited for this double-blind crossover study. All subjects were
given an oral and written account of the study before signing a consent
form. This study was approved by the Ethics Committee of the
Universite´ catholique de Louvain, and the investigation was per-
formed according to the principles outlined in the Declaration of
Helsinki.
Experimental protocol. Before the experiment, subjects partici-
pated in a pretest to determine one repetition maximum (1-RM) for
each leg on a leg-extension apparatus. The exercise consisted of a
one-leg knee extension movement from an angle of 90° to 160°. After
a warm-up comprised of three sets of 10 repetitions at 5 kg, the load
was progressively increased until the subject could not perform more
than one single repetition. Subjects were allowed 2 min of rest
between each set and reached 1-RM within five to six trials.
Subjects were instructed to refrain from vigorous physical
activity 2 days before and during the experimental phase. Food
intake on the evening preceding each muscle biopsy was controlled
by administering a standardized dinner (22% protein, 48% carbo-
hydrate, and 30% fat). Subjects were randomly divided into two
groups: one group (n  5) received 21 g (3  7 g) of oral creatine
monohydrate per day for 5 days before the beginning of the experi-
ment and during the 3 days of the experiment, whereas the second
group (n  4) received a placebo (maltodextrin 3  7 g/day) during
the same period (the protocol is summarized in Fig. 1). During the
experimental days, the subjects were asked to ingest creatine during
the breakfast after biopsy sampling. After a washout period of 6 wk,
the treatments were crossed over for the second trial.
On the first morning of the study, participants reported to the
laboratory after a 10-h overnight fast, and a first biopsy was taken at
rest in the control leg chosen at random. The procedure involved the
administration of local anaesthesia (1% lidocaine) and sample extrac-
tion from the mid portion of the vastus lateralis muscle with a 4-mm
Bergstro¨m biopsy needle. Blood, macroscopically visible fat, and
connective tissue were quickly removed, and the sample was imme-
diately frozen in liquid nitrogen and stored at 80°C.
The exercise was then performed with the other leg after a warm-up
of three sets of 10 repetitions at 5 kg. The main exercise session
consisted of 10 sets of 10 repetitions at 80% of the 1-RM of the
exercising leg, which corresponds to a mean value of positive work of
19,471 1,403.5 J for the placebo trial and 19,902 1,504.1 J for the
creatine one. The positive work of each repetition was calculated by
multiplying the moved mass by g (9.81 m/s2) and by the distance
(height to which the mass was raised). In this calculation, we ne-
glected the friction due to the pulleys. The 1-RM was not exactly the
same for both legs in each subject resulting in different mean work
between placebo and creatine trials. These values were not statistically
different. All subjects performed the same number of repetitions
during both trials. A second biopsy was taken from the exercising leg
within 30 s following the completion of the last repetition. A stan-
dardized breakfast was given after the exercise session (475 kcal; 7%
protein, 74% carbohydrate and 19% fat). Each participant received a
standardized dinner in the evening. Additional biopsies were taken 24
and 72 h later from the exercising leg, each after a 10-h overnight fast.
Protein extraction and cell fractionation. About 20–30 mg of
frozen muscle were ground in a mortar and homogenized in ice-cold
hypotonic buffer [20 mM Hepes, 5 mM sodium fluoride, 1 mM
sodium molybdate, 0.1 mM EDTA, 0.5% NP-40, protease inhibitor
cocktail (Roche Applied Science)] for 5 min on ice. The homogenates
were then centrifuged for 30 s at 10,000 g. The supernatant, contain-
ing the sarcoplasmic proteins, was stored at 80°C. The pellet was
resuspended in a buffer containing 20 mM Hepes, 5 mM sodium
fluoride, 1 mM sodium molybdate, 0.1 mM EDTA, 20% glycerol, a
protease inhibitor cocktail, and the same volume of a saline buffer
containing 20 mM Hepes, 5 mM sodium fluoride, 1 mM sodium
molybdate, 0.1 mM EDTA, 20% glycerol, 0.8 M NaCl, and a protease
inhibitor cocktail. The solution was then homogenized on a rotary
mixer for 30 min at 4°C and centrifuged for 10 min at 10,000 g. The
supernatant, containing the nuclear proteins, was stored at 80°C.
Sarcoplasmic and nuclear protein concentrations were determined
using a protein assay kit (Bio-Rad Laboratories) with BSA as a
standard. Fraction purity was verified and confirmed by immunoblot-
ting for nuclear histone 1 (anti-histone 1, 1:1,000, Santa Cruz).
SDS/PAGE and immunoblotting. Cell lysates (70 g for sarcoplas-
mic proteins and 30 g for nuclear proteins) were combined with
Laemmli sample buffer and separated by SDS/PAGE. After electro-
phoretic separation at 40 mA, the proteins were transferred to a PVDF
membrane at 80 V for 4 h for a Western blot analysis. Membranes
were then incubated in a 5% Blotto solution. Subsequently, mem-
branes were incubated with the following antibodies (1:500) over-
night at 4°C: phospho-PKB Ser 473 (Cell Signaling), phospho-
PKB Thr 308 (Cell Signaling), total PKB (Cell Signaling), phos-
pho-p70s6k Thr 389 (Santa Cruz), total p70s6k (Santa Cruz),
phospho-p38 Thr 180/Tyr 182 (Cell Signaling), total p38 (Cell
Signaling), phospho-ERK1/2 Thr 202/Tyr 204 (Cell Signaling),
total ERK (Cell Signaling), phospho-4E-BP1 Thr 37/46 (Cell
Signaling), total 4E-BP1 (Cell Signaling), and myocyte enhancer
factor-2 (MEF-2) (Santa Cruz). Antibodies from Cell Signaling
were diluted in TBS-Tween containing 1% BSA, and antibodies
from Santa Cruz were diluted in a 5% Blotto solution. PKB
phosphorylated on Thr 308 and Ser 473 was analyzed because the
phosphorylation of both sites is required to achieve a high level of
kinase activity (3).
Membranes were washed in TBS-Tween and incubated for 1 h at
room temperature in a secondary antibody conjugated to horseradish
peroxidase (1:10,000, Cell Signaling). After an additional three
washes, chemiluminescence detection was carried out using an en-
hanced chemiluminescent Western blotting kit (ECL Plus, Amersham
Biosciences) and hyperfilms (Hyperfilm ECL, Amersham Bio-
sciences). Then, the membranes were stripped and reprobed with a
total antibody to verify the relative amount of the analyzed proteinsFig. 1. Experimental protocol.
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through the whole experiment. The films were scanned with an image
scanner using the Labscan software and quantified with the Image
Master 1D Image Analysis Software (Amersham Biosciences). The
results represent the phosphorylated form of the protein. A value of 1
was arbitrarily assigned to the control conditions (placebo preexer-
cise) to which the postexercise and the creatine values were reported.
The choice of this baseline enables depiction of the effects of creatine
supplementation in addition to the effects of acute exercise.
RNA extraction and quantitative real-time PCR. Frozen tissue
samples (	30 mg) were homogenized in TRIZOL using a Polytron.
Total RNA was extracted according to the instructions provided by
the manufacturer. RNA was quantified by spectrophotometry (260
nm), and its concentration was adjusted to 1 g/l using RNase-free
water. A RNA agarose gel was run to verify the integrity of the RNA.
Reverse transcription (RT) was performed using the iScript synthesis
kit (Bio-Rad) on a iQ5 real-time PCR detection system (Bio-Rad),
with 1 g of total RNA in a reaction volume of 20 l (4 l iScript
reaction mix 5, 1 l iScript reverse transcriptase, 1 l RNA
template, 14 l RNase-free water). The final RT product was adjusted
to 140 l using RNase free water. Real-time RT-PCR primers were
designed (Table 1) for human calpain 1, collagen 1(1), C2 subunit of
proteasome, GLUT-4, IL-6, muscle atrophy F-box (MAFbx), myosin
heavy chain (MHC) I, MHC IIA, MyoD, myostatin, proliferating cell
nuclear antigen (PCNA), peroxisome proliferator-activated receptor
gamma coactivator (PGC)-1, and 
2-microglobulin. The latter was
used as the “house-keeping” gene, because preliminary experiments
as well as a previous study (30) had revealed that it was not affected
by either exercise or creatine supplementation. Sybr Green real-time
RT-PCR analyses were carried out on the iQ5 real-time PCR detection
system (Bio-Rad) using the following cycle conditions: 10 min at
95°C, followed by 40 cycles of 1 min at 60°C, and 15 s at 95°C. For
each gene, real-time RT-PCR was conducted in duplicate with 25-l
reaction volume containing 12.5 l of Platinium Sybr Green qPCR
SuperMix UDG (Invitrogen), 0.75 l of each primer (10 pmol/l), 9
l of RNAse-free water, and 2 l of 1:5 diluted cDNA. A melt
analysis was run to verify the amplified DNA product. A value of 1
was arbitrarily assigned to the control conditions (placebo preexer-
cise) to which the postexercise and the creatine values were reported.
Muscle creatine concentration. Muscle creatine concentration was
measured on the preexercise biopsy as previously described (11).
Briefly, a fraction of the muscle biopsy (	15 mg) was used for
spectrophotometric determination of total creatine (i.e., creatine phos-
phate  free creatine). Ground muscle was extracted in 0.25 M
HClO4 and neutralized with 1 M KOH. A fraction of the supernatant
was used to determine free creatine, the remaining serving to deter-
mine total creatine content. To hydrolyze creatine phosphate, 2 M HCl
was added to the supernatant, which was then heated for 15 min at
60°C. The reaction was stopped on ice, and the supernatant was
neutralized with 2 M NaOH. Total creatine was immediately deter-
mined enzymatically using a spectrophotometric method described by
Guder et al. (17) (creatinine PAP, Boerhinger Mannheim, Germany,
from which the creatininase was omitted). Phosphorylcreatine con-
centration was calculated by subtracting free creatine from total
creatine concentrations.
Statistical analysis. The difference in muscle creatine content
between placebo and creatine conditions was tested for signifi-
cance using a paired t-test. Treatment by time interactions were
evaluated using a two-way ANOVA for repeated measures. When
appropriate, Student-Newman-Keuls post hoc tests were applied.
The significance threshold was set to P  0.05. The results are
presented as means  SE.
RESULTS
Muscle creatine concentration. After 5 days of supplemen-
tation muscle total creatine concentration increased by 	20%
(P  0.01) (Table 2).
Transcriptional regulation by exercise and creatine. Imme-
diately after exercise, increases in PCNA mRNA (150%;
P 0.05), MAFbx (70%; P 0.05), MHC IIA (60%; P
0.05), PGC-1 (80%; P  0.05), and IL-6 (350%; P 
0.05) were observed (Fig. 2). The expression of MHC IIA
mRNA, PGC-1, and IL-6 all returned to preexercise values by
24 or 72 h postexercise (P  0.05). At 24 h postexercise,
PCNA mRNA nearly returned to preexercise values before
increasing again at 72 h postexercise (130%; P  0.05).
MAFbx mRNA decreased below preexercise values at 24 h
postexercise (50%; P  0.05) but had returned to basal
values 2 days later. As for MAFbx, mRNA for myostatin
(35%; P  0.01) and GLUT-4 (45%; P  0.01) was also
decreased at 24 h postexercise compared with preexercise
values but had returned to baseline by 72 h postexercise.
Calpain 1 mRNA was increased 72 h postexercise compared
with preexercise (70%), postexercise (20%), and 24 h
postexercise (40%) (P  0.05).
Creatine increased the expression of collagen 1(1)
(250%; P  0.05), GLUT-4 (45%; P  0.05), and MHC I
mRNA (80%; P  0.05) at rest and the expression of MHC
IIA mRNA immediately after exercise (70%; P  0.05).
Activation of the MAPK pathway by exercise. Immediately
after exercise, the phosphorylation state of p38 was increased
Table 1. Sequences of primers used for mRNA quantification by real-time RT-PCR
Forward Reverse Accession Number
Calpain 1 GCC AAG CAG GTG AAC TAC TGA AGT CTC GGA ATG ACA TC NM_005186
Collagen 1(1) GTG CTA AAG GTG CCA ATG GT CTC CTC GCT TTC CTT CCT CT NM_000088
C2 CAT TGA AAA GGG CGC AAT C GCC ATA TCG TTG TGT TGG TA NM_148976
GLUT-4 CAG TAT GTT GCG GAG GCT AT CCT CGA GTT TCA GGT ACT CTT NM_001042
IL-6 TGG ATT CAA TGA GGA GAC TTG GAT TCT TTG CCT TTT TCT GC BT_019749
MAFbx CGA CCT CAG CAG TTA CTG CAA C TTT GCT ATC AGC TCC AAC AGC C NM_058229
MHC I ACA AGC TGC AGC TAA AGG TC TCA AGA TGT GGC AAA GCT AC NM_000257
MHC IIA AGG CTT CAA GAT TTG GTA GA TTC CTT TGC AAC AGG GTA GA NM_017534
MyoD CCG CCT GAG CAA AGT AAA TG GCC CTC GAT ATA GCG GAT G NM_002478
Myostatin CTA CAA CGG AAA CAA TCA TTA CCA GTT TCA GAG ATC GGA TTC CAG TAT NM_005259
PCNA AGG AGG AAG CTG TTA CCA TAG AG AAG TGT CCC ATA TCC GCA AT NM_002592
PGC-1 GAT GAT GGA GAC AGC TAT GGT GAG TCA TAC TTG CTC TTG GTG NM_013261

2-Microglobulin ATG AGT ATG CCT GCC GTG TGA GGC ATC TTC AAA CCT CCA TG NM_004048
Primer sequences: C2, C2 subunit of proteasome; GLUT-4, glucose transporter 4; IL-6, interleukin-6; MAFbx, muscle atrophy F-box; MHC I, myosin heavy
chain type I; MHC IIA, myosin heavy chain type II A; PCNA, proliferating cell nuclear antigen; PGC-1, peroxisome proliferator-activated receptor gamma
coactivator-1.
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more than 10-fold in the sarcoplasm (P  0.05) and more than
20-fold in the nucleus (P  0.01) (Figs. 3 and 5). It returned to
preexercise values 24 and 72 h postexercise in both fractions.
The phosphorylation state of ERK1/2 in the nucleus tended to
be increased by exercise but did not reach the statistical
threshold (P  0.065). Immediately postexercise, the expres-
sion of MEF-2 was doubled in the nucleus (P 0.05). Creatine
had no effect on the phosphorylation state of p38 and ERK1/2
or on the expression of MEF-2 in the nucleus.
Alteration of the PKB pathway by exercise. Immediately
after exercise, the phosphorylation state of PKB on Thr 308
(P  0.05) and 4E-BP1 on Thr 37/46 (P  0.01) decreased by
50 and 75%, respectively, and returned to preexercise values at
24 and 72 h postexercise (Figs. 4 and 5). The same trend to
inhibition was observed immediately postexercise on both
PKB on Ser 473 and on p70s6k on Thr 389, but the statistical
significance was not reached. Twenty-four hours postexercise,
two of the nine subjects showed a markedly elevated phos-
Fig. 2. Effect of creatine supplementation
on the mRNA for myostatin (A), MyoD (B),
proliferating cell nuclear antigen (PCNA;
C), muscle atrophy F-box (MAFbx; D), C2
subunit of proteasome (E), calpain 1 (F),
myosin heavy chain (MHC) I (G), MHC IIA
(H), collagen 1 (1) (I), GLUT-4 (J), perox-
isome proliferator-activated receptor gamma
coactivator-1 (PGC-1; K), and IL-6 (L).
Values are means  SE (n  9) and relative
to the placebo condition before exercise.
*Significant difference (P  0.05) of creat-
ine vs. placebo at the same time point. Two
different letters above the histograms indi-
cate a significant difference (P  0.05) be-
tween the different time points.
Table 2. Creatine, phosphorylcreatine, and total creatine concentrations in muscle
Placebo (n  9) Creatine (n  9) Placebo Trial 1 (n  5) Creatine Trial 2 (n  5) Creatine Trial 1 (n  4) Placebo Trial 2 (n  4)
Cr 9.60.64 12.60.67* 9.20.82 12.91.10* 12.10.78 10.01.11*
PCr 16.31.17 17.60.63 15.71.37 17.30.79 18.11.12 16.92.20
Total Cr 25.81.18 30.20.71† 24.91.18 30.20.78* 30.21.40 26.91.89*
Values are means  SE (mmol/kg wet wt). Free creatine (Cr), phosphorylcreatine (PCr), and total Cr levels after Cr supplementation for 5 days (3 7 g/day).
Results are presented for the nine subjects, for the subgroup of subjects (n  5) receiving placebo during the first trial and Cr during the second trial and for
the subgroup of subjects (n  4) receiving creatine during the first trial and placebo during the second trial. Significnat difference: *P  0.05; †P  0.01.
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phorylation state of p70s6k on Thr 389, whereas it remained
unchanged in the other subjects. Creatine decreased the phos-
phorylation state of PKB on Thr 308 at rest by 60% (P 0.05)
and the phosphorylation state of 4E-BP1 on Thr 37/46 24 h
postexercise by 30% (P  0.05).
DISCUSSION
We designed the studies described above to determine prin-
cipally whether the combination of acute exercise with 5 days
of creatine supplementation would cause a greater than normal
increase in the expression of genes and in signal transduction
likely to be involved in adaptation of muscle size or biochem-
ical properties. Indeed, exercise is known to activate multiple
signal transduction pathways and to modulate transcriptional
and translational processes.
The only significant gene alterations we observed in re-
sponse to creatine supplementation were increases in the ex-
pression of GLUT-4, collagen 1(1), and MHC I mRNA at rest
and increased expression of MHC IIA mRNA immediately
postexercise. Most of the changes in mRNA levels observed in
the present study and elsewhere (11) occurred at rest before the
resistance exercise session. This suggests that, contrary to our
hypotheses, creatine per se is able to modify the expression of
several genes and that exercise training and/or a process of
muscle degeneration/regeneration are not an essential prerequi-
site.
In addition to the modulation of gene expression, creatine
supplementation has been shown to augment the increase in
satellite cells and myonuclei number induced by several weeks
of strength training (32). Therefore, the activation, prolifera-
tion, and differentiation of satellite cells are other mechanisms
by which creatine might increase muscle mass after several
weeks of supplementation combined with training. In the
current study, we found that, although exercise did acutely
increase a marker of satellite cell proliferation (PCNA, a
protein involved in DNA replication maximally expressed in
S phase), there was no prolonged effect over the next 24 h
but a rebound at 72 h and no additional effect of creatine.
MyoD is another key regulator of muscle remodeling asso-
ciated with cell proliferation. We did not observe any
change in MyoD mRNA by creatine nor by exercise,
whereas others found a doubling of MyoD expression im-
mediately postexercise (36) or a peak expression at 8 –12 h
postexercise (45).
Although there is good evidence that the MAPK and the
PKB pathways are involved in the regulation of skeletal muscle
protein synthesis and remodeling by resistance exercise (4, 10,
31, 41), short-term creatine supplementation does not seem to
act via these two cascades to increase muscle mass, contrary to
our hypothesis. Creatine supplementation had no additional
effect on the phosphorylation of p38 and ERK1/2 or on MEF-2
protein expression, nor did creatine increase signaling through
Fig. 3. Effect of creatine supplementation on the phosphoryla-
tion state of sarcoplasmic p38 on Thr 180/Tyr 182 (A), nuclear
p38 on Thr 180/Tyr 182 (B), sarcoplasmic ERK1/2 on Thr
202/Tyr 204 (C), nuclear ERK1/2 on Thr 202/Tyr 204 (D), and
expression of MEF-2 in the nucleus (E). Results are means 
SE (n  9) and relative to the placebo condition before
exercise. Two different letters above the histograms indicate a
significant difference (P  0.05) between the different time
points.
375CHANGES IN GENE EXPRESSION WITH CREATINE AND EXERCISE
J Appl Physiol • VOL 104 • FEBRUARY 2008 • www.jap.org
 o
n
 O
ctober 10, 2008 
jap.physiology.org
D
ow
nloaded from
 
the PKB pathway. The results on the MAPK and the PKB
pathways are in agreement with our previous studies showing
no effect on protein synthesis (25, 26).
Taken together, our results indicate that, although the most
remarkable effects of creatine are seen after several weeks of
supplementation, some of them could be initiated at the tran-
scription level as soon as after 5 days of supplementation.
Nevertheless, the extent of these increases is rather small, and
we have no evidence to relate them to activation of satellite
cells and to muscle mass accumulation observed when creatine
is combined with resistance training (32).
This study also produced novel results in the context of
resistance exercise. These can be summarized as follows: 1) an
acute rise in the expression of MAFbx mRNA seen immedi-
ately at the end of exercise followed by a subsequent fall at
24 h before the return to basal values by 72 h; 2) a fall in
myostatin mRNA at 24 h; 3) PCNA, a marker of cell prolif-
eration, was activated in a biphasic way, increasing immedi-
ately postexercise and after 3 days of recovery; 4) the increases
in both the sarcoplasmic and nuclear complements of p38 and
ERK1/2; 5) the immediate rise after exercise of MEF-2 protein.
Therefore, acute resistance exercise induced very rapid, pro-
nounced alterations in gene transcription and cellular signaling,
indicative of the early modifications of some specific mRNAs
seen at the end of exercise. Additional effects of creatine were
much less pronounced than the effects of exercise alone.
However, since no control group undertook muscle biopsies
without resistance exercise and considering the potential influ-
Fig. 4. Effect of creatine supplementation on the phosphoryla-
tion state of PKB on Thr 308 (A), PKB on Ser 473 (B), 4E-BP1
on Thr 37/46 (C), and p70s6k on Thr 389 (D). Results are
means  SE (n  9) and relative to the placebo condition
before exercise. *Significant difference (P  0.05) of creatine
vs. placebo at the same time point. Two different letters above
the histograms indicate a significant difference (P  0.05)
between the different time points.
Fig. 5. Typical Western blot bands. All bands in one row have
been obtained from one Western blot. p70s6k, p70 ribosomal
protein S6 kinase; 4E-BP1, eukaryotic initiation factor 4E-
binding protein; MEF-2, myocyte enhancer factor 2; sarc,
sarcoplasmic; nucl, nuclear; pre, preexercise; post, postexer-
cise; 24 h, 24 h postexercise; 72 h, 72 h postexercise.
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ence of biopsies sampling on gene expression (38), the effects
of exercise should be analyzed with care.
A large number of studies have shown modulation of mul-
tiple gene clusters in response to resistance exercise stimulus
(5, 36, 45). Indeed, a recent microarray study highlights the
degree of such regulation (22). Furthermore, some gene
changes may be associated with the known effects of resistance
exercise on protein metabolism. It has been suggested that,
during contractile activity, protein synthesis is depressed and
protein breakdown is stimulated. The observed changes in the
component of the ubiquitin/proteasome pathway, MAFbx, fits
in well with this scenario, although we did not assess MAFbx
protein level. The current results are the first to show an acute
upregulation of MAFbx mRNA in human muscle immediately
after exercise, likely to reflect increased protein breakdown at
this time. At 24 h postexercise, MAFbx mRNA expression was
reversed and depressed, suggesting a reduction in protein
degradation.
Myostatin is a negative regulator of muscle mass and
reportedly regulates the expression of MAFbx to modulate
ubiquitin-dependent proteolysis (27). Similar to MAFbx,
24 h postexercise, mRNA for myostatin was depressed. The
decrease in MAFbx and myostatin mRNA observed 24 h
after exercise suggests that the ubiquitin/proteasome path-
way is suppressed at this time after exercise.
Strength training in humans has been shown to result in
MHC IIB-to-IIA transitions without affecting MHC I percent-
age (1). Since the changes in the amounts of the different MHC
mRNA isoforms precede the corresponding changes at the
protein level (19), our data suggest that one bout of exercise
already stimulates the expression of MHC IIA observed after
resistance training (1).
We observed changes in metabolic genes after resistance
exercise. Immediately after exercise, IL-6 mRNA more than
tripled, confirming that skeletal muscle is a major site of IL-6
production (33). GLUT-4 mRNA abundance decreased by 24 h
after exercise. GLUT-4 mRNA seems to be regulated by the
type of exercise. Endurance exercise increased GLUT-4
mRNA (23), whereas the opposite effect was observed after
resistance exercise (6). PGC-1 mRNA has been reported to
increase after resistance exercise, and the maximal expression
level is reached about 3 h after exercise (7, 35, 38). We
observed a significant increase immediately postexercise, sug-
gesting that this coactivator takes part in the early response to
exercise. This suggestion is in agreement with the observation
that p38 is activated and MEF-2 is more abundant in the
nucleus immediately after exercise since the transcriptional
regulation of PGC-1 partially depends on the activation of
both p38 and MEF-2 (2, 44). An increase in the expression of
MEF-2 has already been reported after endurance exercise
(28), but, to the best of our knowledge, this is the first study to
show an increase in MEF-2 after a bout of resistance exercise.
ERK1/2 is another member of the MAPK pathways. Like
p38, ERK1/2 is known to be regulated by exercise (41).
ERK1/2 phosphorylation increased by more than 50-fold in the
sarcoplasm and by about 8-fold in the nucleus, but the statis-
tical significance was not reached due to the large intersubject
variability.
Some studies have reported that resistance exercise activates
the PKB cascade (9, 13); others have observed no changes (8,
9, 12, 14). It was thus surprising to observe a decrease in the
phosphorylation state of PKB on Thr 308 and the downstream
target 4E-BP1 on Thr 37/46. The same trend was found on
PKB on Ser 473 and on p70s6k on Thr 389, but without
reaching the statistical threshold. Recently, there have been
few reports of an inhibition of 4E-BP1 immediately after
exercise in humans (13, 21). The decrease in the PKB phos-
phorylation state fits well with the findings that exercise in the
fasted state decreases protein synthesis and increases protein
breakdown (34). Moreover, the PKB pathway is very sensitive
to nutrients, but since all biopsies were taken in the fasted state
this could have blunted the activation of the PKB pathway
generally observed during the recovery period (10). It is likely
that the results would have been different if the subjects were
in a fed state.
In summary, it is generally accepted that the effects of
exercise training are the results of incremental addition of
repeated bouts of exercise. We found evidence to suggest that
creatine induces changes in the expression of certain targeted
genes as early as after 5 days of supplementation and in
association with a single session of resistance exercise. The
increase in collagen 1(1) and MHC I-IIA mRNA by creatine
might improve muscle framework, providing a favorable en-
vironment for muscle mass accretion after a few weeks of
training. However, we have no evidence of a modulation of
translational signaling when resistance exercise is coupled to
creatine supplementation.
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